Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios
Source: SeekingAlpha
2026-03-25 21:43:44 ET
Johnson & Johnson (JNJ) is a true Dividend King with more than 60 years of consecutive dividend growth. In this uncertain market, investing in a dividend juggernaut with above-inflation long-term growth is just the medicine your portfolio needs. Conservative dividend growth investors should have the name in their portfolios....
Read the full article on Seeking Alpha
For further details see:
Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
2.61% G/L:
$210.491 Last:
2,117,184 Volume:
$206.2562 Open:
ABBV Latest News
April 08, 2026 12:33:51 pm
Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
